UK Regulator Won't Refer Thermo Fisher's Acquisition of PPD for Further Review
03 Diciembre 2021 - 1:47AM
Noticias Dow Jones
By Jaime Llinares Taboada
The U.K. Competition and Markets Authority said Friday that it
has decided it won't refer Thermo Fisher Scientific Inc.'s planned
$17.4 billion acquisition of pharmaceutical-testing company PPD
Inc. to a phase 2 investigation.
The regulator had announced a probe into the deal in October, to
see if it would lead to a lessening of competition.
Write to Jaime Llinares Taboada at jaime.llinares@wsj.com;
@JaimeLlinaresT
(END) Dow Jones Newswires
December 03, 2021 02:32 ET (07:32 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
PPD (NASDAQ:PPD)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
PPD (NASDAQ:PPD)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about PPD Inc (NASDAQ): 0 recent articles
Más de PPD Inc Artículos de Noticias